Coronavirus COVID-19
Palabras clave: América Latina | Coronavirus | COVID-19 | Diagnóstico | Epidemiología |
SARS-CoV-2 | Tratamiento | Síntomas | Vacunas |
Información destacada
Psychological factors associated with reporting side effects following COVID-19 vaccination: A prospective cohort study (CoVAccS – Wave 3)
ABSTRACT Objective: To investigate symptom reporting following the first and second COVID-19 vaccine doses, attribution of symptoms to the vaccine, and factors associated with symptom
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
ABSTRACT The recent clinical success of multiple mRNA-based SARS-CoV-2 vaccines has proven the potential of RNA formulated in lipid nanoparticles (LNPs) in humans, and products
The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells
ABSTRACT SARS-CoV-2 was shown to infect and persist in the human brain cells up to 230 days, highlighting the need to treat the brain viral
Enlaces Coronavirus COVID-19
Publicaciones seleccionadas por el CONCYTEC
